Results 121 to 130 of about 54,634 (147)
Some of the next articles are maybe not open access.
Immunology Letters, 2001
Although HIV-specific cellular immune responses are found in a number of HIV highly-exposed, persistently seronegative (HEPS) cohorts, late seroconversion can occur despite pre-existing cytotoxic T lymphocytes (CTL), suggesting that a protective HIV vaccine may need to induce a broader range of HIV-specific immune responses.
K. Broliden +9 more
openaire +3 more sources
Although HIV-specific cellular immune responses are found in a number of HIV highly-exposed, persistently seronegative (HEPS) cohorts, late seroconversion can occur despite pre-existing cytotoxic T lymphocytes (CTL), suggesting that a protective HIV vaccine may need to induce a broader range of HIV-specific immune responses.
K. Broliden +9 more
openaire +3 more sources
Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children
Annual Review of Medicine, 2016Globally, 240,000 infants are newly infected with HIV-1 each year and 3.2 million children are living with the infection. Combination antiretroviral therapy (cART) has reduced HIV-1-related disease and mortality in children but is not curative owing to the early generation of a latent reservoir of long-lived memory CD4+T cells bearing replication ...
openaire +2 more sources
Animal models of HIV-1 latency and persistence.
Current opinion in HIV and AIDS, 2009In this review we address the animal models currently in use to study HIV-1 latency and persistence. We outline the rationale behind each model, the major scientific findings made, and discuss the extent of their relevance to HIV-1.Several animal models have allowed the complex area of viral latency to be studied in vivo. These models are, by necessity,
Helen J, Brown, Jerome A, Zack
openaire +1 more source
Persisting HIV-1 Replication Triggered by Acute Hepatitis a Virus Infection
Antiviral Therapy, 2000We report the case of two patients in whom acute hepatitis A was associated with a marked and prolonged increase in human immunodeficiency virus type 1 (HIV-1) viral load. Although in one patient the rise in HIV-1 RNA might also have been related to the interruption of antiretroviral therapy, we also observed a similar pattern in the other patient who
A. L. Ridolfo +4 more
openaire +3 more sources
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly
Prevention, treatment and cure of HIV infection
Nature Reviews Microbiology, 2023Raphael J Landovitz +2 more
exaly
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Nature Reviews Microbiology, 2017Mahdad Noursadeghi
exaly
Animal models for HIV/AIDS research
Nature Reviews Microbiology, 2012Theodora Hatziioannou, David T Evans
exaly
HIV-1 capsid: the multifaceted key player in HIV-1 infection
Nature Reviews Microbiology, 2015Edward M Campbell, Thomas J Hope
exaly